A Phase 1, Randomized, Placebo Controlled, Crossover Study to Evaluate the Efficacy of GSK1440115 After a Single Oral Dose in Patients With Asthma.
Phase of Trial: Phase I
Latest Information Update: 17 May 2013
At a glance
- Drugs GSK 1440115 (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 01 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 01 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2011 New trial record